• Search
    Latest News
  • Gibraltar Govt Press Release re Epidemiological Study


    GOVERNMENT OF GIBRALTAR
    PRESS OFFICE
    No.6 Convent Place
    Gibraltar
    Tel:20070071; Fax: 20043057
    PRESS RELEASE
    No: 10/2011
    Date: 17th January 2011
    “EPIDEMIOLOGICAL STUDY INTO CANCERS IN GIBRALTAR SHOWS THAT TOTAL
    CANCER INCIDENCE RATE IN GIBRALTAR IS WITHIN THE NORMAL RANGE OF
    OTHER EUROPEAN COUNTRIES AND THAT GIBRALTAR IS NOT A HIGH RISK
    COMMUNITY FOR CANCER”
    For many years there has been speculation in Gibraltar about whether the incidence of
    cancers in Gibraltar was abnormally high, and if so whether this is explicable by
    reference to some local or regional cause.
    The Government of Gibraltar has a manifesto commitment to investigate this issue, and
    had for several years been attempting to conduct this study jointly with the appropriate
    Spanish authorities in order that the investigation could take account of and report on a
    wider regional basis. This did not prove possible and therefore, in accordance with its
    commitment the Gibraltar Government has proceeded alone.
    Already, back in the beginning of the last decade, the Gibraltar Government had
    established a Cancer Registry to collect cancer incidence data in Gibraltar, without which
    a Study of these issues would have been impossible.
    In discharge of its commitment to establish the position in respect of these important
    questions, the Government of Gibraltar commissioned renowned experts in these matters
    from the National Environmental Research Institute of Aarhus University, Denmark to
    conduct an Epidemiological study into cancers in Gibraltar. They are renowned experts in
    the conduct of such studies. The study was conducted by Dr Hans Sanderson and Dr
    Patrik Fauser, both of the National Environmental Research Institute of Aarhus University
    The Epidemiological Study Report into cancers in Gibraltar, dated 22 December 2010 is
    being published today. The full report is available on the Gibraltar Government website.
    Attached to this press statement is a copy of the Report’s Executive Summary and
    Conclusions, which provides answers to 6 fundamental questions.
    The Report points out two relevant contextual facts, namely:
    (1) The global burden of cancer is increasing, especially in the developed world.
    Globally one in two men and one in three women will be diagnosed with cancer
    during their lifetime. For one in three of these women the diagnosis will be breast
    cancer;
    (2) The cancer incidence rate increases exponentially with age especially at 60+years
    of age. Accordingly, as populations grow older, that is the ratio of older people as a
    proportion of the whole increases, so does the cancer rate and the proportion of the
    population affected by cancer.
    The main findings of the Study are that:
    • the total cancer incidence rate in Gibraltar is within the normal range of other
    European countries;
    • Gibraltar is not a high risk community for cancer;
    • The total cancer incidence rate in Gibraltar for the whole population is at the EU
    average. Attached is a copy of Table 3.14 of the Study Report showing Gibraltar’s
    position in relation to all EU countries and the EU average;
    • The cancer rate for men only is in the lower quarter of the EU range with only four
    EU countries having a lower rate than Gibraltar. Attached is a copy of Table 3.16 of
    the Study Report showing Gibraltar’s position in respect of men only in relation to
    all EU countries and the EU average;
    • The total cancer incidence rate in Gibraltar for women only is in the upper quarter
    of the range of EU countries, but still within the normal range for EU countries.
    Attached is a copy of Table 3.15 of the Study Report showing Gibraltar’s position in
    relation to women only within the EU;
    • In summary, cancer incidence rates in Gibraltar among men is below the EU
    average and for women it is above the EU average but well within the normal EU
    range. The difference between the men and women rates in Gibraltar relative to the
    EU average is due mainly to breast cancer.
    • Breast cancer represents 38% of cancers in women and is a priority type. Breast
    cancer is the most frequent type among European women. The incidence rate
    among Gibraltarian women is higher than the EU average and at the upper end,
    with a similar rate to Denmark, UK and Switzerland;
    • Measured concentrations of carcinogens in the air pollution exposures in Gibraltar
    are within the normal ranges of EU cities;
    The Government, including the Public Health and Environmental authorities will study the
    Report in detail to establish whether any actions or further studies are called for in respect
    of any aspect of the Report.



  •